A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease

BACKGROUND: Hyperphosphatemia in patients with chronic kidney disease (CKD) contributes to secondary hyperparathyroidism, soft tissue calcification, and increased mortality risk. This trial was conducted to examine the efficacy and safety of calcium acetate in controlling serum phosphorus in pre-dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Qunibi, Wajeh, Winkelmayer, Wolfgang C, Solomon, Richard, Moustafa, Moustafa, Kessler, Paul, Ho, Chiang-Hong, Greenberg, Jonathan, Diaz-Buxo, Jose A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055808/
https://www.ncbi.nlm.nih.gov/pubmed/21324193
http://dx.doi.org/10.1186/1471-2369-12-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055808/
https://www.ncbi.nlm.nih.gov/pubmed/21324193
http://dx.doi.org/10.1186/1471-2369-12-9

Ejemplares similares